Home   >  
MAPK Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Sodium Taurodeoxycholate Chemical Structure
BCP16412 Sodium Taurodeoxycholate 1180-95-6
Sodium taurodeoxycholate is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier.
Tauroursodeoxycholic acid sodium salt Chemical Structure
BCP14861 Tauroursodeoxycholic acid sodium salt 35807-85-3
Tauroursodeoxycholate Sodium is an ambiphilic bile acid that helps with liver and gallbladder issues.
LM22B-10 Chemical Structure
BCP30139 LM22B-10 342777-54-2
LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor, and can induce TrkB, TrkC, AKT and ERK activation in vitro and in vivo.
KO947 HCl Chemical Structure
BCP29926 KO947 HCl KO947HCL
KO-947 is a potent and selective ERK inhibitor with slow dissociation kinetics.
FR 180204 Chemical Structure
BCP09857 FR 180204 865362-74-9
FR180204 is a potent and selective ATP-competitive inhibitor of ERK1 and ERK2 with Ki value of 0.31 uM and 0.14 uM respectively; has IC50 values of 0.51 and 0.33 μM in enzymatic assays against ERK1 and ERK2, respectively.
XMD 8-92 Chemical Structure
BCP03605 XMD 8-92 1234480-50-2
XMD8-92 is highly selective ERK5/BMK1 inhibitor (KD values are 80, 190, 600 and 890 nM for BMK1, DCAMKL2, PLK4 and TNK1 respectively).
AZD-0364 Chemical Structure
BCP29508 AZD-0364 2097416-76-5
AZD-0364 is a potent and selective ERK2 inhibitor extracted from patent WO2017080979A1, compound example 18, has an IC50 of 0.6 nM.
RG7304 Chemical Structure
BCP28658 RG7304 213406-50-9
RG7304, also known as CK-127, is a MEK inhibitor currently in clinical trials.
XL-518 racemate Chemical Structure
BCP20611 XL-518 racemate 934662-91-6
Cobimetinib(GDC-0973; XL518) is a potent, highly selective inhibitor of MEK1/2.
Cobimetinib R-enantiomer Chemical Structure
BCP20607 Cobimetinib R-enantiomer 934660-94-3
Cobimetinib (R-enantiomer) is a selective inhibitor of MEK. It is also known as mitogen activated protein kinase kinase (MAPKK) and is a key component of the RAS/RAF/MEK/ERK pathway, which is frequently activated in human tumors.
123下一页末页共 57 条记录 1 / 6 页